GSTM1 and lung carcinoma: The prevalence of anemia (defined as hemoglobin [Hb] < 11 g/dL) in patients with lung cancer ranges from 50% to 60%, and blood transfusions are common, with 30% to 40% of patients requiring this treatment [6,7].